Navigation Links
Microfluidics Enters into Exclusive Partnership with ATS Scientific to Expand Distribution in Canada
Date:1/13/2010

NEWTON, Mass., Jan. 13 /PRNewswire-FirstCall/ -- Microfluidics (OTC Bulletin Board: MFLU) has partnered with ATS Scientific, Inc. (Burlington, Ontario) to be the exclusive distributor of Microfluidizer® high shear fluid processors and related services throughout the majority of Canada. ATS, which recently celebrated its twentieth anniversary as a nationwide distributor of scientific equipment, maintains a portfolio of synergistic products, including HORIBA particle size analyzers.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090811/NE59652LOGO )

"We are very pleased to welcome ATS to the Microfluidics family," said Brian Ayling, Regional Sales Manager at Microfluidics. "Microfluidics has always had a strong presence in the pharmaceutical industry in Canada.  ATS will join Garland Technical Services, which represents the greater Vancouver area, to work with scientists on the new generation of smart materials that is a focus of Canadian researchers. "

In addition, ATS will manage importation logistics and CSA certification relevant to Microfluidics technology.

"Adding this well-established line of high shear fluid processors to our portfolio allows us to provide a more complete solution to solve processing challenges for customers," said Gilles Groulx, National Sales Manager at ATS Scientific. "We see great synergy with our existing products in material handling and processing which will create excellent cross-marketing activities and even more choices for our clients."

To add focus to this expanded product range, ATS has promoted Joseph Emili to Product Manager focused on material processing and characterization.

ABOUT ATS SCIENTIFIC, INC.

ATS Scientific, Inc. is a private, 100% Canadian Owned distributor of Scientific Instrumentation and Supplies, based in Burlington, Ontario.  Since inception in 1989 offering nationwide sales and service, excellent growth and profitability has been maintained. In 2000, the head office was relocated to our current 8000 square foot facility, which includes office and warehousing space, along with a full service centre, a demonstration/application lab and a state of the art training room.  This growth has been accomplished with the commitment of our specialized staff, along with the offering of high quality products to the Canadian Marketplace.

ABOUT MICROFLUIDICS

Microfluidics (OTC Bulletin Board: MFLU) is the exclusive producer of Microfluidizer® high shear fluid processors for uniform particle size reduction, robust cell disruption and bottom-up nanoparticle creation. Used primarily by pharmaceutical, biotechnology, chemical, cosmetic, nutraceutical/food and energy companies to research, develop and improve products with efficient processes, more than 3,000 Microfluidizer processors are installed at customer sites in 50 countries around the world. The innovative Microfluidics Technology Center, located at the company's headquarters outside Boston, Mass., is staffed by expert engineers with a wide range of nanotechnology and application experience for Proof of Concept and Process Development services.

By producing smaller particle sizes and a more narrow distribution than other technologies, with scaleup from lab to production guaranteed, Microfluidics enables companies to create tiny particles that achieve big results. To learn more, visit www.microfluidicscorp.com.

SOURCE Microfluidics

RELATED LINKS
http://www.microfluidicscorp.com

'/>"/>

SOURCE Microfluidics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
2. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
5. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
6. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
9. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
10. AcroMetrix Renews Contract With Group Services for Americas Blood Centers
11. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Dec. 9, 2016  Axovant Sciences Ltd. (NYSE: ... company focused on the treatment of dementia, today ... a Phase 2b trial evaluating treatment with intepirdine ... with donepezil plus placebo in people with mild-to-moderate ... of intepirdine to treatment was associated with reduced ...
(Date:12/8/2016)... -- KEY FINDINGS ... Patient warming and cooling devices offer ... lowering the risks of neurological disorders post cardiac arrests, rapid ... warming systems can be segmented into convective warming system, surface ... the stay at hospitals thus, lowering the healthcare costs by ...
(Date:12/8/2016)... Inc. (NYSE: DPLO) has been recognized by the Detroit Free ... To learn more about Diplomat,s career opportunities, visit ... ... ... a research firm specializing in organizational health and workplace improvement. The ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... ... a Property owned by an affiliate of Seavest, has won a prestigious national ... Southern Chester County ambulatory care center (ACC) was named “Best New Development, MOBs ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the nation’s ... groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, announced ... J. Hennessy, Jr said, “CURE Media Group is honored to team up with Upstage ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. ... DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig ... Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference ...
(Date:12/8/2016)... ... 2016 , ... SunView Software aims to redefine IT self-service ... engaging and easy to use. Coming off the heels of a successful launch ... plans to roll out new AI-powered self-service enhancements to help organizations implement effective ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... up in 2006 as a non-profit organization to unite pharmaceutical and healthcare companies ...
Breaking Medicine News(10 mins):